Equities

CEL AI PLC

CEL AI PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)0.20
  • Today's Change-0.025 / -11.11%
  • Shares traded90.06k
  • 1 Year change-68.00%
  • Beta--
Data delayed at least 20 minutes, as of May 03 2024 16:40 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

CEL AI PLC, formerly Cellular Goods PLC, is a United Kingdom-based wellness company that provides premium products based on lab-made cannabinoids. The Company is engaged in developing and marketing premium skincare and wellness products that help people look, feel and function better. The Company’s primary focus is on three product verticals: Feel Better, Look Better and Function Better. These three verticals encompass Cellular Goods' premium cannabigerol (CBG) skincare and CBD wellness. The Company's products include rejuvenating cannabinoid face serum, SPF 25 rejuvenating day cream, rejuvenating night cream, rejuvenating day mousse, nourishing face oil travel size and various others. The Company’s products are available direct to the consumer through its Website, e-commerce sites, such as Amazon and through physical retail partnerships.

  • Revenue in GBP (TTM)67.23k
  • Net income in GBP-3.31m
  • Incorporated2018
  • Employees5.00
  • Location
    CEL AI PLC9th Floor, 16 Great Queen StreetLondon WC2B 5DGUnited KingdomGBR
  • Phone+44 207 031 6871
  • Websitehttps://cellular-goods.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NOSIUM AB (publ)1.38m-1.65m394.83k12.00--0.0777--0.2869-0.1187-0.11870.11340.16720.37256.5122.161,557,333.00-48.74-33.04-62.62-45.82-1.470.5097-130.85-49.821.37-0.51640.1346--20.7023.34-2,018.12--80.00--
Mastrad SA4.09m-445.10k763.46k5.00--0.3167--0.1867-0.0046-0.00460.04270.03410.78357.154.61681,285.70-8.56-18.25-14.45-29.09-10.8032.38-10.92-16.422.13-4.530.3076---12.481.44-17.49--0.0566--
Ellen AB1.88m-224.48k1.03m6.00--2.42--0.5455-0.3516-0.35163.030.52162.64--8.21---31.39-41.96-69.13-65.90-----11.91-26.001.24-58.78----7.036.7836.16---36.65--
CEL AI PLC67.23k-3.31m1.20m5.00--0.5323--17.92-0.0062-0.00620.00010.00380.01770.04751.0313,446.00-87.32---93.03--61.64---4,922.71--10.04--0.00--132.66--44.75------
Zenova Group PLC208.00k-1.70m2.59m----0.6678--12.47-0.0182-0.01820.00220.02770.05571.801.03---45.60---47.31--61.06---818.75--2.49-169.300.0691--2,816.67---75.78------
Photocat A/S1.73m-186.10k5.59m12.00--3.8898.063.23-0.4325-0.43254.033.350.65032.673.281,957,542.00-6.99-13.56-9.10-16.5884.9577.01-10.75-20.421.07-2.610.307--1.3626.8145.85--23.90--
Data as of May 03 2024. Currency figures normalised to CEL AI PLC's reporting currency: UK Pound GBX
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.